Companion Diagnosis for Retinal Neuroprotective Treatment by Real-Time Imaging of Calpain Activation Using a Novel Fluorescent Probe.


Journal

Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319

Informations de publication

Date de publication:
16 09 2020
Historique:
pubmed: 26 8 2020
medline: 22 6 2021
entrez: 26 8 2020
Statut: ppublish

Résumé

Calpain activation induces retinal ganglion cell (RGC) death, while calpain inhibition suppresses RGC death, in animal studies. However, the role of calpain in human retinal disease is unclear. This study investigated a new strategy to study the role of calpain based on real-time imaging. We synthesized a novel fluorescent probe for calpain, acetyl-l-leucyl-l-methionine-hydroxymethyl rhodamine green (Ac-LM-HMRG) and used it for real-time imaging of calpain activation. The toxicity of Ac-LM-HMRG was evaluated with a lactate dehydrogenase cytotoxicity assay, retinal sections, and electroretinograms. Here, we performed real-time imaging of calpain activation in a rat model. First, we administered

Identifiants

pubmed: 32840357
doi: 10.1021/acs.bioconjchem.0c00435
doi:

Substances chimiques

((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester 0
Carbamates 0
Enzyme Inhibitors 0
Fluorescent Dyes 0
Neuroprotective Agents 0
Rhodamines 0
Calpain EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2241-2251

Auteurs

Toshifumi Asano (T)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.

Yuri Nagayo (Y)

Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

Satoru Tsuda (S)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.

Azusa Ito (A)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.

Wataru Kobayashi (W)

Department of Retinal Disease Control, Ophthalmology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

Kosuke Fujita (K)

Department of Retinal Disease Control, Ophthalmology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

Kota Sato (K)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.
Collaborative Program of Ophthalmic Drug Discovery, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

Koji M Nishiguchi (KM)

Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Miyagi 980-8574, Japan.

Hiroshi Kunikata (H)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.
Department of Retinal Disease Control, Ophthalmology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

Hiroyoshi Fujioka (H)

Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-8654, Japan.

Mako Kamiya (M)

Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

Yasuteru Urano (Y)

Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

Toru Nakazawa (T)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.
Department of Retinal Disease Control, Ophthalmology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Collaborative Program of Ophthalmic Drug Discovery, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Miyagi 980-8574, Japan.
Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Miyagi 980-8574, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH